|
据Chemical
) [+ I2 H: {3 N5 {9 g" |
6 d7 V- \! x% Q: {* O$ `/ ~watch 12月4日发布的消息,关于第二批15个待定的高关注度物质,各成员国已经一致同意将其确定SVHC,ECHA预计这15个物质正式归入SVHC清单的时间约在2010年1月份左右。 [$ z) L& ^; Z3 h7 ~
, \- _( h3 m3 N0 p* D' i8 L1 Q: ]$ C) \9 h
英文来不及翻译,将就着看吧3 R) M, k8 g8 o, I
All substances in latest raft of nominations unanimously accepted5 G- [0 G& A, ~4 X7 k
04-Dec-2009 ' O( X2 ^$ l2 O# B9 S+ z
Your free trial ends on 18 December ; C# }& f8 M. h
3 G/ F$ H2 y; s5 u6 _
2009. Subscribe Today
! e- F; ]7 W& a$ PThe Member States Committee of the European Chemical Agency (ECHA) has unanimously agreed that a further 15 substances of very high
- m, l( c0 ~/ u: a5 v! C% ]9 x
9 L/ f M) Z3 G! y$ h, O5 a5 Qconcern (SVHC) should be included on the REACH Candidate List of substances that may require authorisation under REACH.
. z% Y' V0 R& M" c) U4 LThe substances include five forms
$ l# d% m6 _& b4 W+ k* `1 e0 O K9 ~6 q
of the polyaromatic hydrocarbon anthracene, which is used to make rubber products. All are considered to be persistent, bioaccumulative and toxic. The others
! W. q" g: \! o4 D5 Y9 q
0 f$ X, d" m; ?are high temperature coal tar pitch; acrylamide; 2,4-dinitrotoluene; lead chromate molybdate sulphate red; lead sulphochromate yellow; tris(2-chloroethyl)
4 L+ a% |3 o( S0 I
6 B, ]& J0 M& W$ x+ Kphosphate;diisobutyl phthalate; aluminosilicate refractory ceramic fibres; zirconia aluminosilicate refractory fibres and lead chromate. Eight of the . F. I4 n K* W: q2 X0 w. M
! {9 O2 F" T2 vnominations came from Germany (CW 1 September 2009& k( F& w3 g( s2 v) }2 q. n
ECHA is expected to formally adopt the decision and publish the 15 substances identified as SVHCs on
5 \0 D$ y# M H; J$ L5 w" e; g" h$ s- |- G, O- W( s4 I6 T% ~
the Candidate List in January, bringing the total on the list to 30. This will trigger the right of consumers to ask for information about their inclusion in
! I3 M; ^1 }: G& c% k5 N
8 z# U/ J& }' [: Mproducts, with a right of reply within 45 days.
, b! i' i) x6 kThe Agency is expected to recommend which of the substances should be prioritised for authorisation, and
* C0 X8 k t# M2 y2 Q: U' Q8 E$ T' E# h6 T
thus included in Annex XIV, sometime in the second half of next year.
- q# [1 {7 k2 R8 H7 Y7 E# w7 EThe committee also discussed ECHA's progress in refining its approach to the 8 T) i) @7 c! F
+ Q: r8 q* d- { I( O4 Wprioritisation of SVHCs for inclusion in Annex XIV. Its approach is based on legal requirements set out in Article 58(3) of REACH, which defines three main + [- H% A! t# c" w
8 n; m% p; d2 x2 [) I
prioritisation criteria – being produced in high volumes; or exhibiting persistent, bioaccumulative and toxic (PBT) properties or very persistent, very
! ~: p8 A( o% G& F2 X0 i# L, i; z4 h% V
bioaccumulative (vPvB) properties; or having wide dispersive use.
& V+ h8 m8 Y2 B1 }0 t6 m/ EAccording to ECHA's guidance on its general approach to prioritisation, issued in June,
: n; m% o5 s/ w' l- g1 B* V7 F+ M0 W, \1 E2 A! k! @5 F" u* D
the three “are assessed together in a weight of evidence approach in a qualitative, where possible semi-quantitative manner, resulting in an overall
0 B* }. F# v8 }2 s) d2 O% d0 P8 a. g4 C( X, h
conclusion on the priority of the substance. The number of criteria met and the extent to which the criteria are fulfilled (i.e. the higher the rating of the
3 @3 j- E8 B$ p7 a( D$ v* b' U. `1 V" P
intrinsic properties, the more wide dispersive the uses and the higher the volumes not exempted from authorisation) are important factors in deciding whether 0 ?7 B9 j, f" N$ V
# _# o9 v, D) G- b- V. a
or not to prioritise a substance.”9 Z! t- u; g( i7 O4 ^6 z
The committee supported ECHA's proposals but decided there are some small details that can be improved. One example
( b. ?" q+ I2 x; Y* K5 E% t( x$ g/ l+ ^/ Z
would be to introduce a scoring system for information that is available, such as volume, with a substance's score varying according to its production
7 n# q$ H0 `6 l. J- o M" y$ b0 `- _1 ^. m, A, i
volume. This would help to make ECHA's decisions more transparent. The Agency's proposals will be re-examined at the committee's next meeting on 27-28
. T4 O4 u1 e) n6 T" y5 S, N1 R2 P9 V3 \ P5 R& P9 e, z) R
April.
* Y9 J1 k# j! h y; zThe committee also discussed its first draft decision from the Agency on a REACH registrant's testing proposal, and accepted it unanimously.
. Z. }. U/ @& F
A6 ]% _% H: f' }Details concerning the substance and registrant involved are confidential. The committee expects to receive further Agency draft decisions relating to / C X( d h7 G6 g" z8 a! a) S, j! S
6 f. y. m8 q' i6 u7 Edossier compliance checks and testing proposals in the spring. |
|